Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhi-Yong Liang

Showing results (1-10 of 88) with videos related to

Pageof 9
Sort By:
Chronic Diseases and Translational Medicine|October 25, 2017
Circulating free DNA in the era of precision oncology: Pre- and post-analytical concernsJun-Liang Lu, Zhi-Yong Liang
Chinese Medical Journal|September 22, 2020
Circulating tumor DNA in lung cancer: real-time monitoring of disease evolution and treatment responseRui-Yu Li, Zhi-Yong Liang
IEEE/ACM Transactions on Computational Biology and Bioinformatics|February 11, 2017
Identifying Sigma70 Promoters with Novel Pseudo Nucleotide CompositionHao Lin, Zhi-Yong Liang, Hua Tang, et al.
Pathology|March 4, 2020
High MMP14 expression is predictive of poor prognosis in resectable hepatocellular carcinomaYe Jin, Zhi-Yong Liang, Wei-Xun Zhou, et al.
Zhonghua Bing Li Xue Za Zhi = Chinese Journal of Pathology|January 11, 2013
[Relationship between EGFR and KRAS mutations and prognosis in Chinese patients with non-small cell lung cancer: a mutation analysis with real-time polymerase chain reaction using scorpion amplification refractory mutation system]Jie Gao, Jia-qi Chen, Li Zhang, et al.
Cancer Biomarkers : Section a of Disease Markers|October 24, 2019
Expression, clinicopathologic and prognostic significance of plasminogen activator inhibitor 1 in hepatocellular carcinomaYe Jin, Zhi-Yong Liang, Wei-Xun Zhou, et al.
Analytica Chimica Acta|January 11, 2023
A new quinoline based probe with large Stokes shift and high sensitivity for formaldehyde and its bioimaging applicationsZhi-Yong Liang, Na Wei, Xiao-Feng Guo, et al.
Journal of Cancer|August 19, 2017
Expression and Significances of G-Protein-Coupled Receptor Kinase 3 in Hepatocellular CarcinomaYe Jin, Zhi-Yong Liang, Wei-Xun Zhou, et al.
Hepatology International|January 3, 2019
Plasminogen activator inhibitor 2 (PAI2) inhibits invasive potential of hepatocellular carcinoma cells in vitro via uPA- and RB/E2F1-related mechanismsYe Jin, Zhi-Yong Liang, Wei-Xun Zhou, et al.
Future Oncology (London, England)|July 21, 2022
An MMP-based risk score strongly distinguishes prognosis in hepatocellular carcinoma after resectionYe Jin, Zhi-Yong Liang, Wei-Xun Zhou, et al.
Pageof 9

Showing results (1-10 of 88) with videos related to

Sort By:
Pageof 9
Chronic Diseases and Translational Medicine|October 25, 2017
Circulating free DNA in the era of precision oncology: Pre- and post-analytical concernsJun-Liang Lu, Zhi-Yong Liang
Chinese Medical Journal|September 22, 2020
Circulating tumor DNA in lung cancer: real-time monitoring of disease evolution and treatment responseRui-Yu Li, Zhi-Yong Liang
IEEE/ACM Transactions on Computational Biology and Bioinformatics|February 11, 2017
Identifying Sigma70 Promoters with Novel Pseudo Nucleotide CompositionHao Lin, Zhi-Yong Liang, Hua Tang, et al.
Pathology|March 4, 2020
High MMP14 expression is predictive of poor prognosis in resectable hepatocellular carcinomaYe Jin, Zhi-Yong Liang, Wei-Xun Zhou, et al.
Zhonghua Bing Li Xue Za Zhi = Chinese Journal of Pathology|January 11, 2013
[Relationship between EGFR and KRAS mutations and prognosis in Chinese patients with non-small cell lung cancer: a mutation analysis with real-time polymerase chain reaction using scorpion amplification refractory mutation system]Jie Gao, Jia-qi Chen, Li Zhang, et al.
Cancer Biomarkers : Section a of Disease Markers|October 24, 2019
Expression, clinicopathologic and prognostic significance of plasminogen activator inhibitor 1 in hepatocellular carcinomaYe Jin, Zhi-Yong Liang, Wei-Xun Zhou, et al.
Analytica Chimica Acta|January 11, 2023
A new quinoline based probe with large Stokes shift and high sensitivity for formaldehyde and its bioimaging applicationsZhi-Yong Liang, Na Wei, Xiao-Feng Guo, et al.
Journal of Cancer|August 19, 2017
Expression and Significances of G-Protein-Coupled Receptor Kinase 3 in Hepatocellular CarcinomaYe Jin, Zhi-Yong Liang, Wei-Xun Zhou, et al.
Hepatology International|January 3, 2019
Plasminogen activator inhibitor 2 (PAI2) inhibits invasive potential of hepatocellular carcinoma cells in vitro via uPA- and RB/E2F1-related mechanismsYe Jin, Zhi-Yong Liang, Wei-Xun Zhou, et al.
Future Oncology (London, England)|July 21, 2022
An MMP-based risk score strongly distinguishes prognosis in hepatocellular carcinoma after resectionYe Jin, Zhi-Yong Liang, Wei-Xun Zhou, et al.
Pageof 9